Soluble epoxide hydrolase activity and pharmacologic inhibition in horses with chronic severe laminitis

A. Guedes, L. Galuppo, D. Hood, S. H. Hwang, C. Morisseau, B. D. Hammock

Research output: Contribution to journalArticlepeer-review

29 Scopus citations


Background: The roles of soluble epoxide hydrolase and lipid mediators in inflammatory and neuropathic pain could be relevant in laminitis pain management. Objectives: To determine soluble epoxide hydrolase (sEH) activity in the digital laminae, sEH inhibitor potency in vitro, and efficacy of a sEH inhibitor as an adjunct analgesic therapy in chronic laminitic horses. Study design: In vitro experiments and clinical case series. Methods: sEH activity was measured in digital laminae from euthanised healthy and laminitic horses (n = 5–6/group). Potency of 7 synthetic sEH inhibitors was determined in vitro using equine liver cytosol. One of them (t-TUCB; 0.1 mg/kg bwt i.v. every 24 h) was selected based on potency and stability, and used as adjunct therapy in 10 horses with severe chronic laminitis (Obel grades 2, one horse; 3–4, nine horses). Daily assessments of forelimb lifts, pain scores, physiologic and laboratory examinations were performed before (baseline) and during t-TUCB treatment. Data are presented as mean ± s.d. and 95% confidence intervals (CI). Results: sEH activity in the digital laminae from laminitic horses (0.9±0.6 nmol/min/mg; 95% CI 0.16–1.55 nmol/min/mg) was significantly greater (P = 0.01) than in healthy horses (0.17±0.09 nmol/min/mg; CI 0.07–0.26 nmol/min/mg). t-TUCB as an adjunct analgesic up to 10 days (4.3±3 days) in laminitic horses was associated with significant reduction in forelimb lifts (36±22%; 95% CI 9–64%) and in pain scores (18±23%; 95% CI 2–35%) compared with baseline (P = 0.04). One horse developed gas colic and another corneal vascularisation in a blind eye during treatment. No other significant changes were observed. Main limitations: Absence of control group and evaluator blinding in case series. Conclusions: sEH activity is significantly higher in the digital laminae of actively laminitic compared with healthy horses, and use of a potent inhibitor of equine sEH as adjunct analgesic therapy appears to decrease signs of pathologic pain in laminitic horses.

Original languageEnglish (US)
Pages (from-to)345-351
Number of pages7
JournalEquine veterinary journal
Issue number3
StatePublished - May 1 2017

Bibliographical note

Publisher Copyright:
© 2016 EVJ Ltd


  • fatty acid
  • hoof
  • horse
  • hyperalgesia
  • lameness
  • neuropathic pain


Dive into the research topics of 'Soluble epoxide hydrolase activity and pharmacologic inhibition in horses with chronic severe laminitis'. Together they form a unique fingerprint.

Cite this